Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield – NDTV

The Covovax shot developed by American vaccine-maker Novavax would cost a “low single dollar” price per dose but is likely to be costlier than Covishield, company’s CEO Stanley Erck said in an exclusive interview. Read More